Further Amendment to Duties Addressing the Synthetic Opioid Supply Chain in the People’s Republic of China as Applied to Low-Value Imports

This week, we delve into a significant development in the ongoing battle against the synthetic opioid crisis. We break down a new Presidential Executive Order, issued on April 2nd, 2025, that further amends duties specifically targeting low-value imports originating from the People's Republic of China. This order aims to disrupt the flow of illicit substances, particularly synthetic opioids like fentanyl, into the United States by addressing deceptive shipping practices that exploit the de minimis exemption – a loophole allowing many low-value packages to enter the country duty-free.